Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 958 of 1,261

  1. US 7981935

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  2. US 7982044

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  3. US 7981931

    Pharmaceutical compositions of short-acting sedative hypnotic agent

    Theravance, Inc. · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  4. US 7981869

    RNAi modulation of RSV and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  5. US 7981598

    Preventive/remedy for respiratory diseases

    Takeda Pharmaceutical Company Limited · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  6. US 7981864

    Methods and compositions for targeting proteins across the blood brain barrier

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  7. US 7981618

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    The Board of Regents of the University of Texas System · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  8. US 7982014

    FGFR3-IIIc fusion proteins

    Five Prime Therapeutics, Inc. · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  9. US 7981610

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  10. US 7982011

    Mutated anti-cd22 antibodies and immunoconjugates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  11. US 7977488

    1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  12. US 7976868

    Liposomes comprising duramycin and anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  13. US 7976851

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  14. US 7976832

    Active topical skin protectants containing amines, polyalkenimines and /or derivatives

    The United States of America as represented by the Secretary of the Army · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  15. US 7977359

    5-lipdxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  16. US 7977457

    Fusion proteins, uses thereof and processes for producing same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  17. US 7977312

    Compositions and methods for increasing bone mineralization

    Darwin Discovery Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  18. US 7976936

    Endoprostheses

    UNIVERSITY OF CONNECTICUT · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  19. US 7976853

    Process for producing coated preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  20. US 7976834

    Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  21. US 7976743

    Gas-containing liposomes

    The Board of Regents of the University of Texas System · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  22. US 7977322

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  23. US 7977320

    Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents

    The Regents of the University of California · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  24. US 7977468

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.